Angioedema with normal C1q and C1 inhibitor: An atypical presentation of Waldenström macroglobulinemia

Anas Khanfar, Anita Trikha, Rana Bonds, Bagi Jana

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Angioedema is a recurrent, non-pitting, non-pruritic, transitory swelling due to transient increase of endothelial permeability in the capillaries of the deep cutaneous and mucosal layers. Angioedema is generally categorized based on etiology, and characteristic lab findings are associated with each category. Cases of acquired angioedema associated with myeloproliferative disorders have been described in the literature, but these have been associated with a characteristic low C1q, a defining laboratory finding in acquired angioedema. Here we present a case of 68-year-old female with acquired angioedema that was not associated with low C1q, but was found to have Waldenström disease. Her angioedema responded dramatically to combination therapy consisting of bortezomib, rituximab, and dexamethasone.

Original languageEnglish (US)
Pages (from-to)654-656
Number of pages3
JournalInternational Journal of Hematology
Volume97
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Waldenstrom Macroglobulinemia
Angioedema
Myeloproliferative Disorders
Capillary Permeability
Dexamethasone
Skin
Acquired angioedema
Therapeutics

Keywords

  • Acquired angioedema
  • Angioedema
  • C1q
  • Waldenström macroglobulinemia

ASJC Scopus subject areas

  • Hematology

Cite this

Angioedema with normal C1q and C1 inhibitor : An atypical presentation of Waldenström macroglobulinemia. / Khanfar, Anas; Trikha, Anita; Bonds, Rana; Jana, Bagi.

In: International Journal of Hematology, Vol. 97, No. 5, 05.2013, p. 654-656.

Research output: Contribution to journalArticle

Khanfar, Anas ; Trikha, Anita ; Bonds, Rana ; Jana, Bagi. / Angioedema with normal C1q and C1 inhibitor : An atypical presentation of Waldenström macroglobulinemia. In: International Journal of Hematology. 2013 ; Vol. 97, No. 5. pp. 654-656.
@article{0d6d02596b2342fcb86c97889db0539a,
title = "Angioedema with normal C1q and C1 inhibitor: An atypical presentation of Waldenstr{\"o}m macroglobulinemia",
abstract = "Angioedema is a recurrent, non-pitting, non-pruritic, transitory swelling due to transient increase of endothelial permeability in the capillaries of the deep cutaneous and mucosal layers. Angioedema is generally categorized based on etiology, and characteristic lab findings are associated with each category. Cases of acquired angioedema associated with myeloproliferative disorders have been described in the literature, but these have been associated with a characteristic low C1q, a defining laboratory finding in acquired angioedema. Here we present a case of 68-year-old female with acquired angioedema that was not associated with low C1q, but was found to have Waldenstr{\"o}m disease. Her angioedema responded dramatically to combination therapy consisting of bortezomib, rituximab, and dexamethasone.",
keywords = "Acquired angioedema, Angioedema, C1q, Waldenstr{\"o}m macroglobulinemia",
author = "Anas Khanfar and Anita Trikha and Rana Bonds and Bagi Jana",
year = "2013",
month = "5",
doi = "10.1007/s12185-013-1330-z",
language = "English (US)",
volume = "97",
pages = "654--656",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Angioedema with normal C1q and C1 inhibitor

T2 - An atypical presentation of Waldenström macroglobulinemia

AU - Khanfar, Anas

AU - Trikha, Anita

AU - Bonds, Rana

AU - Jana, Bagi

PY - 2013/5

Y1 - 2013/5

N2 - Angioedema is a recurrent, non-pitting, non-pruritic, transitory swelling due to transient increase of endothelial permeability in the capillaries of the deep cutaneous and mucosal layers. Angioedema is generally categorized based on etiology, and characteristic lab findings are associated with each category. Cases of acquired angioedema associated with myeloproliferative disorders have been described in the literature, but these have been associated with a characteristic low C1q, a defining laboratory finding in acquired angioedema. Here we present a case of 68-year-old female with acquired angioedema that was not associated with low C1q, but was found to have Waldenström disease. Her angioedema responded dramatically to combination therapy consisting of bortezomib, rituximab, and dexamethasone.

AB - Angioedema is a recurrent, non-pitting, non-pruritic, transitory swelling due to transient increase of endothelial permeability in the capillaries of the deep cutaneous and mucosal layers. Angioedema is generally categorized based on etiology, and characteristic lab findings are associated with each category. Cases of acquired angioedema associated with myeloproliferative disorders have been described in the literature, but these have been associated with a characteristic low C1q, a defining laboratory finding in acquired angioedema. Here we present a case of 68-year-old female with acquired angioedema that was not associated with low C1q, but was found to have Waldenström disease. Her angioedema responded dramatically to combination therapy consisting of bortezomib, rituximab, and dexamethasone.

KW - Acquired angioedema

KW - Angioedema

KW - C1q

KW - Waldenström macroglobulinemia

UR - http://www.scopus.com/inward/record.url?scp=84878015878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878015878&partnerID=8YFLogxK

U2 - 10.1007/s12185-013-1330-z

DO - 10.1007/s12185-013-1330-z

M3 - Article

C2 - 23591717

AN - SCOPUS:84878015878

VL - 97

SP - 654

EP - 656

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 5

ER -